Inventor
LAWRENCE NICHOLAS J
US29 patents
⚠️ This page may combine multiple inventors who share the name “LAWRENCE NICHOLAS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LEE MOFFITT CANCER CT & RES
21 patentsUS10336734B2Jul 2, 2019
Inhibitors of ACK1/TNK2 tyrosine kinase
H LEE MOFFITT CANCER CT & RES7 citations80
US11730726B2Aug 22, 2023
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
H LEE MOFFITT CANCER CT & RES2 citations70
US11530182B2Dec 20, 2022
YAP1 inhibitors that target the interaction of YAP1 with Oct4
H LEE MOFFITT CANCER CT & RES2 citations69
US10906874B2Feb 2, 2021
YAP1 inhibitors that target the interaction of YAP1 with OCT4
H LEE MOFFITT CANCER CT & RES2 citations69
US10526291B2Jan 7, 2020
Potent dual BRD4-kinase inhibitors as cancer therapeutics
H LEE MOFFITT CANCER CT & RES2 citations67
US10106507B2Oct 23, 2018
Potent dual BRD4-kinase inhibitors as cancer therapeutics
H LEE MOFFITT CANCER CT & RES2 citations66
US11571418B2Feb 7, 2023
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES0 citations62
US9968599B2May 15, 2018
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES1 citations62
US12391676B2Aug 19, 2025
BRD4-JAK2 inhibitors
H LEE MOFFITT CANCER CT & RES0 citations60
US12187686B2Jan 7, 2025
BRD4-JAK2 inhibitors
H LEE MOFFITT CANCER CT & RES0 citations60
US11643396B2May 9, 2023
BRD4-kinase inhibitors as cancer therapeutics
H LEE MOFFITT CANCER CT & RES0 citations60
US12564583B2Mar 3, 2026
Small molecules against cereblon to enhance effector T cell function
H LEE MOFFITT CANCER CT & RES0 citations59
US12233054B2Feb 25, 2025
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
H LEE MOFFITT CANCER CT & RES0 citations59
US11999695B2Jun 4, 2024
YAP1 inhibitors that target the interaction of YAP1 with OCT4
H LEE MOFFITT CANCER CT & RES0 citations59
US11395820B2Jul 26, 2022
Small molecules against cereblon to enhance effector t cell function
H LEE MOFFITT CANCER CT & RES0 citations59
US10813927B2Oct 27, 2020
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES0 citations52
US10738016B2Aug 11, 2020
BRD4-kinase inhibitors as cancer therapeutics
H LEE MOFFITT CANCER CT & RES0 citations50
US11685725B2Jun 27, 2023
YAP1 inhibitors that target the interaction of YAP1 with OCT4
H LEE MOFFITT CANCER CT & RES0 citations48
US10017478B2Jul 10, 2018
Inhibitors of ACK1/TNK2 tyrosine kinase
H LEE MOFFITT CANCER CT & RES1 citations48
US9850216B2Dec 26, 2017
Inhibitors of ACK1/TNK2 tyrosine kinase
H LEE MOFFITT CANCER CT & RES1 citations48
US9622993B2Apr 18, 2017
Thiosemicarbazones inhibitors of lysophosphatidic acid acyltransferase and uses thereof
H LEE MOFFITT CANCER CT & RES1 citations46